Sanofi (SNY) stock and Roche (RHHBY) stock trade flat after the duo reaffirmed 2025 forecasts despite strong Q1 results. Read ...

An experimental vaccine for acne could someday transform the way patients with the condition are treated, according to the ...

The pharmaceutical company said the profit was driven by a higher gross margin and slower operating expense growth.

France's Sanofi reported first-quarter profit that beat analysts' expectations on Thursday, boosted by strong demand for its ...

Two of Europe’s biggest drugmakers said they’re looking at ways to protect themselves from US President Donald Trump’s ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...

The company reiterated its financial outlook for the year but is struggling to predict the likely impact of pharmaceutical ...

As Sanofi anticipates sales of immunotherapy juggernaut Dupixent reaching a major $22 billion by the end of the decade, ...

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma ...

Scientists are testing and working on the world’s first acne vaccine, hoping to offer a long-term alternative to current ...

Up to five-year contract extension to support the WFH Humanitarian Aid Program with medicine donations and financial ...

Muthoot Finance, Sanofi India share prices will remain in focus on Friday as will trade ex-dividend today. In addition Ami ...